Casein kinase 1 regulates Sprouty2 in FGF-ERK signaling

Oncogene

Volumn 34, Issue 4, 2015, Pages 474-484

  Yim, D G R ^a,b,d   Ghosh, S ^a   Guy, G R ^b,e   Virshup, D M ^a,c  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d GENOME INSTITUTE OF SINGAPORE   (Singapore)

^e GRG   (Malaysia)

Author keywords

casein kinase 1; gastric cancer; Growth factor signaling; neurite outgrowth; SPRY

Indexed keywords

CASEIN KINASE I; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; GRB2 PROTEIN, HUMAN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MEMBRANE PROTEIN; NERVE PROTEIN; SIGNAL PEPTIDE; SPRY2 PROTEIN, HUMAN; SPRY2 PROTEIN, RAT;

ANIMAL; CELL CULTURE; HUMAN; METABOLISM; NEURITE; PHOSPHORYLATION; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; STOMACH TUMOR;

ANIMALS; CASEIN KINASE I; CELLS, CULTURED; FIBROBLAST GROWTH FACTORS; GRB2 ADAPTOR PROTEIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NEURITES; PHOSPHORYLATION; RATS; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 85028222653     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.564     Document Type: Article

References (52)

1. Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010; 141: 1117-1134.
2. Casaletto JB, McClatchey AI. Spatial regulation of receptor tyrosine kinases in development and cancer. Nat Rev Cancer 2012; 12: 387-400.
3. Casci T, Vinos J, Freeman M. Sprouty an intracellular inhibitor of Ras signaling. Cell 1999; 96: 655-665.
4. Impagnatiello MA, Weitzer S, Gannon G, Compagni A, Cotten M, Christofori G. Mammalian sprouty-1 and-2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J Cell Biol 2001; 152: 1087-1098.
5. Yusoff P, Lao DH, Ong SH, Wong ES, Lim J, Lo TL et al. Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J Biol Chem 2002; 277: 3195-3201.
6. Wong ES, Fong CW, Lim J, Yusoff P, Low BC, Langdon WY et al. Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling. EMBO J 2002; 21: 4796-4808.
7. Hausott B, Vallant N, Auer M, Yang L, Dai F, Brand-Saberi B et al. Sprouty2 downregulation promotes axon growth by adult sensory neurons. Mol Cell Neurosci 2009; 42: 328-340.
8. Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA. sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 1998; 92: 253-263.
9. Metzger RJ, Klein OD, Martin GR, Krasnow MA. The branching programme of mouse lung development. Nature 2008; 453: 745-750.
10. Tang N, Marshall WF, McMahon M, Metzger RJ, Martin GR. Control of mitotic spindle angle by the RAS-regulated ERK1/2 pathway determines lung tube shape. Science 2011; 333: 342-345.
11. Lo TL, Yusoff P, Fong CW, Guo K, McCaw BJ, Phillips WA et al. The ras/mitogenactivated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Res 2004; 64: 6127-6136.
12. Fong CW, Chua MS, McKie AB, Ling SH, Mason V, Li R et al. Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Res 2006; 66: 2048-2058.
13. Patel R, Gao M, Ahmad I, Fleming J, Singh LB, Rai TS et al. Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression. J Clin Invest 2013; 123: 1157-1175.
14. Edwin F, Anderson K, Ying C, Patel TB. Intermolecular interactions of Sprouty proteins and their implications in development and disease. Mol Pharmacol 2009; 76: 679-691.
15. Guy GR, Jackson RA, Yusoff P, Chow SY. Sprouty proteins: modified modulators, matchmakers or missing links? J Endocrinol 2009; 203: 191-202.
16. Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 2010; 10: 116-129.
17. Lao DH, Chandramouli S, Yusoff P, Fong CW, Saw TY, Tai LP et al. A Src homology 3-binding sequence on the C terminus of Sprouty2 is necessary for inhibition of the Ras/ERK pathway downstream of fibroblast growth factor receptor stimulation. J Biol Chem 2006; 281: 29993-30000.
18. Hanafusa H, Torii S, Yasunaga T, Nishida E. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol 2002; 4: 850-858.
19. Lao DH, Yusoff P, Chandramouli S, Philp RJ, Fong CW, Jackson RA et al. Direct binding of PP2A to Sprouty2 and phosphorylation changes are a prerequisite for ERK inhibition downstream of fibroblast growth factor receptor stimulation. J Biol Chem 2007; 282: 9117-9126.
20. DaSilva J, Xu L, Kim HJ, Miller WT, Bar-Sagi D. Regulation of sprouty stability by Mnk1-dependent phosphorylation. Mol Cell Biol 2006; 26: 1898-1907.
21. Chandramouli S, Yu CY, Yusoff P, Lao DH, Leong HF, Mizuno K et al. Tesk1 interacts with Spry2 to abrogate its inhibition of ERK phosphorylation downstream of receptor tyrosine kinase signaling. J Biol Chem 2008; 283: 1679-1691.
22. Aranda S, Alvarez M, Turro S, Laguna A, de la Luna S. Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A. Mol Cell Biol 2008; 28: 5899-5911.
23. Flotow H, Graves PR, Wang AQ, Fiol CJ, Roeske RW, Roach PJ. Phosphate groups as substrate determinants for casein kinase I action. J Biol Chem 1990; 265: 14264-14269.
24. Cegielska A, Virshup DM. Control of simian virus 40 DNA replication by the HeLa cell nuclear kinase casein kinase I. Mol Cell Biol 1993; 13: 1202-1211.
25. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001; 291: 1040-1043.
26. Rubinfeld B, Tice DA, Polakis P. Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase 1epsilon. J Biol Chem 2001; 276: 39037-39045.
27. Okamura H, Garcia-Rodriguez C, Martinson H, Qin J, Virshup DM, Rao A. A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1. Mol Cell Biol 2004; 24: 4184-4195.
28. Badura L, Swanson T, Adamowicz W, Adams J, Cianfrogna J, Fisher K et al. An inhibitor of casein kinase I epsilon induces phase delays in circadian rhythms under free-running and entrained conditions. J Pharmacol Exp Ther 2007; 322: 730-738.
29. Cheong JK, Nguyen TH, Wang H, Tan P, Voorhoeve PM, Lee SH et al. IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1delta/varepsilon and Wnt/beta-catenin independent inhibition of mitotic spindle formation. Oncogene 2011; 30: 2558-2569.
30. Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M et al. Axinmediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 2002; 16: 1066-1076.
31. Lord C, Bhandari D, Menon S, Ghassemian M, Nycz D, Hay J et al. Sequential interactions with Sec23 control the direction of vesicle traffic. Nature 2011; 473: 181-186.
32. Rena G, Bain J, Elliott M, Cohen P. D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Rep 2004; 5: 60-65.
33. Lim J, Yusoff P, Wong ES, Chandramouli S, Lao DH, Fong CW et al. The cysteinerich sprouty translocation domain targets mitogen-activated protein kinase inhibitory proteins to phosphatidylinositol 4,5-bisphosphate in plasma membranes. Mol Cell Biol 2002; 22: 7953-7966.
34. Lim J, Wong ES, Ong SH, Yusoff P, Low BC, Guy GR. Sprouty proteins are targeted to membrane ruffles upon growth factor receptor tyrosine kinase activation. Identification of a novel translocation domain. J Biol Chem 2000; 275: 32837-32845.
35. Gross I, Armant O, Benosman S, de Aguilar JL, Freund JN, Kedinger M et al. Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival. Cell Death Differ 2007; 14: 1802-1812.
36. Greer YE, Rubin JS. Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-dependent neurite outgrowth. J Cell Biol 2011; 192: 993-1004.
37. Birrer MJ, Johnson ME, Hao K, Wong KK, Park DC, Bell A et al. Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas. J Clin Oncol 2007; 25: 2281-2287.
38. Smith G, Ng MT, Shepherd L, Herrington CS, Gourley C, Ferguson MJ et al. Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer. Br J Cancer 2012; 107: 1327-1336.
39. Nakazawa K, Yashiro M, Hirakawa K. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Cancer Res 2003; 63: 8848-8852.
40. Toyokawa T, Yashiro M, Hirakawa K. Co-expression of keratinocyte growth factor and K-sam is an independent prognostic factor in gastric carcinoma. Oncol Rep 2009; 21: 875-880.
41. Ooi CH, Ivanova T, Wu J, Lee M, Tan IB, Tao J et al. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet 2009; 5: e1000676.
42. Lei Z, Tan IB, Das K, Deng N, Zouridis H, Pattison S et al. Identification of molecular subtypes of gastric cancer with different responses to pi3-kinase inhibitors and 5-fluorouracil. Gastroenterology 2013; 145: 554-565.
43. Cheong JK, Virshup DM. Casein kinase 1: complexity in the family. Int J Biochem Cell Biol 2011; 43: 465-469.
44. Swiatek W, Tsai IC, Klimowski L, Pepler A, Barnette J, Yost HJ et al. Regulation of casein kinase I epsilon activity by Wnt signaling. J Biol Chem 2004; 279: 13011-13017.
45. Liu F, Virshup DM, Nairn AC, Greengard P. Mechanism of regulation of casein kinase I activity by group I metabotropic glutamate receptors. J Biol Chem 2002; 277: 45393-45399.
46. Pullar CE, Chen J, Isseroff RR. PP2A activation by beta2-adrenergic receptor agonists: novel regulatory mechanism of keratinocyte migration. J Biol Chem 2003; 278: 22555-22562.
47. Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L et al. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 2011; 377: 1929-1937.
48. Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 2009; 8: 235-253.
49. Chow SY, Yu CY, Guy GR. Sprouty2 interacts with protein kinase C delta and disrupts phosphorylation of protein kinase D1. J Biol Chem 2009; 284: 19623-19636.
50. Tsai IC, Amack JD, Gao ZH, Band V, Yost HJ, Virshup DM. A Wnt-CKIvarepsilon-Rap1 pathway regulates gastrulation by modulating SIPA1L1, a Rap GTPase activating protein. Dev Cell 2007; 12: 335-347.
51. Meng QJ, Logunova L, Maywood ES, Gallego M, Lebiecki J, Brown TM et al. Setting clock speed in mammals: the CK1 epsilon tau mutation in mice accelerates circadian pacemakers by selectively destabilizing PERIOD proteins. Neuron 2008; 58: 78-88.
52. Wong ES, Lim J, Low BC, Chen Q, Guy GR. Evidence for direct interaction between Sprouty and Cbl. J Biol Chem 2001; 276: 5866-5875.